| Features | |
| Active substance | Telmisartan |
| Also known as | Pritor, Kinzalmono |
| Blood pressure | Reduces systolic and diastolic blood pressure |
| Chemical name | 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid |
| Dosage (medical) | Typically 20-80 mg once daily |
| Dosage (sports) | Not applicable as not typically used for performance enhancement |
| Effects | Lowers blood pressure, reduces strain on the heart |
| Formula | C33H30N4O2 |
| Half-life | 24 hours |
| Hepatotoxicity | Low risk |
| Lab Test | Blood pressure monitoring, renal function tests |
| Main action | Antihypertensive, blocks angiotensin II receptors |
| Side effects | Dizziness, hypotension, fatigue, diarrhea, upper respiratory tract infections |
| Storage conditions | Store at room temperature, protect from moisture and light |
| Strength | 80mg |
| Substance class | Angiotensin II receptor antagonist |
| Trade name | Micardis |
| Use in sports | Not commonly used in sports |
| Water Retention | Low risk |
| Manufacturer | Glenmark Pharmaceuticals Ltd. |
| Packing | 15 tabs/blister |